Eupraxia Pharmaceuticals Inc. - Common Stock (EPRX)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — May 6, 2026Investment Snapshot
- P/B of 3.16 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -47.0%
Eupraxia Pharmaceuticals Inc. - Common Stock (EPRX) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $259 million . Key value metrics: P/B ratio 3.16, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Eupraxia Pharmaceuticals Inc. - Common Stock — Fundamental Analysis Summary
On financial health, EPRX shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -47.0% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 8.74.
StockPik's composite Value Score for EPRX is 40/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EPRX shows earnings declining at 51%.